Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Bravaccini

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
The Breast Journal|October 16, 2019
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?Michela Palleschi, Roberta Maltoni, Samanta Sarti, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 24, 2005
Usefulness of immunological detection of the human telomerase reverse transcriptaseAnnalisa Volpi, Sara Bravaccini, Laura Medri, et al.
Journal of Clinical Pathology|November 1, 2011
Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approachesSara Bravaccini, Claudia Rengucci, Laura Medri, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiotaFrancesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, et al.
Diagnostic Pathology|September 12, 2020
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be goldRoberta Maltoni, Michela Palleschi, Sara Ravaioli, et al.
Oncotarget|November 12, 2016
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histologySara Ravaioli, Sara Bravaccini, Maria Maddalena Tumedei, et al.
Journal of Lower Genital Tract Disease|September 10, 2016
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ HybridizationSara Ravaioli, Maria M Tumedei, Andrea Amadori, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2020
Are we ready to use TMB in breast cancer clinical practice?Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, et al.
Analytical Cellular Pathology (Amsterdam)|May 19, 2012
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CINSara Bravaccini, Andrea Amadori, Emanuela Scarpi, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
The Breast Journal|October 16, 2019
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?Michela Palleschi, Roberta Maltoni, Samanta Sarti, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 24, 2005
Usefulness of immunological detection of the human telomerase reverse transcriptaseAnnalisa Volpi, Sara Bravaccini, Laura Medri, et al.
Journal of Clinical Pathology|November 1, 2011
Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approachesSara Bravaccini, Claudia Rengucci, Laura Medri, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiotaFrancesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, et al.
Diagnostic Pathology|September 12, 2020
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be goldRoberta Maltoni, Michela Palleschi, Sara Ravaioli, et al.
Oncotarget|November 12, 2016
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histologySara Ravaioli, Sara Bravaccini, Maria Maddalena Tumedei, et al.
Journal of Lower Genital Tract Disease|September 10, 2016
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ HybridizationSara Ravaioli, Maria M Tumedei, Andrea Amadori, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2020
Are we ready to use TMB in breast cancer clinical practice?Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, et al.
Analytical Cellular Pathology (Amsterdam)|May 19, 2012
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CINSara Bravaccini, Andrea Amadori, Emanuela Scarpi, et al.
Pageof 15